• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Molecular biological study on the role of autoimraunity in tumor associated neurological diseases.

Research Project

Project/Area Number 12670620
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Neurology
Research InstitutionTokyo Woman's Medical University

Principal Investigator

HASHIMOTO Shiori  Tokyo Women's Medical University, Dep. Med., 医学部, 助手 (60180824)

Project Period (FY) 2000 – 2001
Project Status Completed (Fiscal Year 2001)
Budget Amount *help
¥1,100,000 (Direct Cost: ¥1,100,000)
Fiscal Year 2001: ¥1,100,000 (Direct Cost: ¥1,100,000)
KeywordsImmunoglobulins / autoimmune diseases / 腫瘍随伴神経筋疾患 / 自己免疫
Research Abstract

The presence of antigen-driven mechanism for production of auto antibodies has been suggested, based on their molecular characterization of CDR (complement determining region)-3 regions. In the present study, we tried to isolate auto-reactive B cells by flow cytometry, using B cell-specific monoclonal antibody, such as CD19, as well as auto-antigens including citrullination filaggrins and ribosomal P antigens. In the field of neurology, the well-characterized auto-antigens include acetyicholine receptors (AchR) in myasthenia gravis. However, AchR consists of several subunits, so we chose the rheumatoid arthritis autoantigen (citrullination filaggrins) and CNS-lupus autoantigens (ribosomal P antigens) for further experiments. The analysis of CDR3 regions of immunoglobulin genes from tonsil B cells were performed by RTPCR using total RNA from tonsils as template, specific primers (VH1-6) and isotype specific primer, which were subsequently cloned in TA vectors and sequenced by automated sequencer. However, we can not detect the autoreactive B cells by flow cytometry, even using the EAS method, which increase the sensitivity of flow cytometry. Our data suggests that the frequency of antireactive B cells in autoimmune disease might be very low.

Report

(3 results)
  • 2001 Annual Research Report   Final Research Report Summary
  • 2000 Annual Research Report
  • Research Products

    (4 results)

All Other

All Publications (4 results)

  • [Publications] Sawada T, Hashimoto S, et al.: "Inhibition of L-leucine methyl ester mediated killing of THP-1, a human monocytic cell line, by a new anti-inflammatory drug, T614"Immunopharmacology. 49・3. 285-294 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Sawada T, Hashimoto S, et al: "Inhibition of L-leucine methyl ester mediated killing of THP-1, a human monocytic cell line, by a new anti-inflammatory drug. T614."Immunopharmacology. 49, 3. 285-294 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Sawada T, Hashimoto S, et al: "Inhibition of L-leucine methyl ester mediated killing of THP-1, a human monocytic cell line, by a new anti-inflammatory drug, T614"Immunopharmacology. 49・3. 285-294 (2000)

    • Related Report
      2001 Annual Research Report
  • [Publications] Sawada T,Hashimoto S et al.: "Inhibition of L-leucine methyl ester mediated killing of THP-1, a human monocytic cell line, by a new anti-inflammatory drug, T614."Immunopharmacology. 49・3. 285-294 (2000)

    • Related Report
      2000 Annual Research Report

URL: 

Published: 2001-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi